TrialThe oncologist2024

Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.

Marianne Pavel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.